|
|
|
|
|
by geysersam
729 days ago
|
|
The article mentioned they are expected to make 3x the claimed RnD costs already this year, not sure what fraction of that is profits, but probably quite a large chunk. There's no risk they won't recoup the costs even if prices were reduced 10x in the US. > There’s so many areas of medicine where we don’t see progress because the ROI just isn’t worth it .. because it's so much more profitable making medicines in demand in rich countries than medicines that benefit the largest number of people. |
|